United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 10/20/2011 8:35:35 AM : Outperform Start Price: $39.72 UTHR Score: -9.38

Franchise Player.

Featured Broker Partners


Advertisement